Virginia Tech researchers have identified a biomarker in pre-diabetic individuals that could help prevent them from developing Type II diabetes.
Aug 19, 2015
0
9
Although metformin was introduced as a treatment for type 2 diabetes nearly 60 years ago and is now the recommended first-line treatment for newly diagnosed patients, researchers still debate precisely how the drug works. ...
Aug 18, 2015
1
178
Among overweight and obese patients with type 2 diabetes, daily injection of the diabetes drug liraglutide with a modified insulin pen device, in addition to diet and exercise, resulted in greater weight loss over 56 weeks ...
Aug 18, 2015
0
36
Researchers have shown the biomarker role of certain circulatory microRNAs (miRNAs) characteristic of "Asian Indian phenotype' in patients with type 2 diabetes – a metabolic disease referred to as 'madhumeha' in Ayurveda. ...
Aug 17, 2015
0
14
(HealthDay)—In patients with type 2 diabetes, characteristics and biomarkers of β-cell failure are associated with glycemic response to GLP-1 receptor agonist (GLP-1RA) therapy, according to a study published online Aug. ...
Aug 10, 2015
0
5
A study has found that physical activity provides the greatest benefits to adolescent insulin resistance - a risk factor for type 2 diabetes - when the condition peaks at age 13, but provides no benefit to it at age 16. The ...
Aug 5, 2015
0
28
(HealthDay)—Personalized blood sugar self-monitoring benefits people with type 2 diabetes even if they're not taking insulin, a new small study shows.
Aug 5, 2015
0
49
New research from Harvard T.H. Chan School of Public Health describes a molecular mechanism that helps explain how obesity-related inflammation can lead to type 2 diabetes. The findings describe a surprising connection between ...
Jul 30, 2015
0
153
Babies conceived by women who drink alcohol around the time of conception face dramatically increased risks of type 2 diabetes and obesity in early middle age, a University of Queensland study has found.
Jul 30, 2015
1
27
(HealthDay)—For canagliflozin-treated patients with type 2 diabetes, the incidence of serious adverse events of diabetic ketoacidosis (DKA) is low, according to research published online July 22 in Diabetes Care.
Jul 29, 2015
0
8
